Toggle Nav
My Cart
Search
Advanced Search
Menu
Account
Settings

Global Molecular Diagnostics Market, Forecast to 2029

Global Molecular Diagnostics Market, Forecast to 2029

Molecular Diagnostics Unleash Growth Opportunities, Steering Innovation Personalized Medicine

RELEASE DATE
22-Apr-2024
REGION
Global
Deliverable Type
Market Research
Research Code: PFEE-01-00-00-00
SKU: CM_2024_672
AvailableYesPDF Download
$4,950.00
In stock
SKU
CM_2024_672

Global Molecular Diagnostics Market, Forecast to 2029
Published on: 22-Apr-2024 | SKU: CM_2024_672

Need more details?
$4,950.00
DownloadLink
Request Sample
Add to Compare
Need more details?
Description

The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities.

Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment.

The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan’s forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints.

The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.

Infographic
Table of Contents

Growth Environment

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on the Global Molecular Diagnostics Industry

Strategic Imperatives for Global Molecular Diagnostics Companies

Growth Opportunities Fuel the Growth Pipeline Engine™

Scope of Analysis

Global Molecular Diagnostics Application Segmentation

Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Global Molecular Diagnostics Revenue Forecast Analysis

Global Molecular Diagnostics Revenue Forecast Analysis (continued)

Revenue Forecast by Region

Global Molecular Diagnostics Revenue Forecast Analysis by Region

Global Molecular Diagnostics Revenue Forecast Analysis by Region (continued)

Global Molecular Diagnostics Revenue Forecast Analysis by Region (continued)

Global Molecular Diagnostics Market Analysis by Technology

Global Molecular Diagnostics Market Analysis by Technology (continued)

Revenue Forecast by Application

Global Molecular Diagnostics Revenue Forecast by Application

Global Molecular Diagnostics Revenue Forecast by Application (continued)

Global Molecular Diagnostics Revenue Forecast by Application (continued)

Global Molecular Diagnostics Revenue Forecast by Application (continued)

Competitive Environment

Global Molecular Diagnostics Revenue Share by Player

Global Molecular Diagnostics Revenue Share Analysis

Key Competitors

Competitive Mapping by Molecular Diagnostics Offering

Competitive Mapping by Molecular Diagnostics Offering (continued)

Global Molecular Diagnostics Market: Notable M&A

Global Molecular Diagnostics Market: Notable M&A (continued)

Molecular Diagnostics Companies to Watch

Growth Opportunity Summary

Growth Opportunity 1: Advancements in Point-of-care Testing

Growth Opportunity 1: Advancements in Point-of-care Testing (continued)

Growth Opportunity 2: Personalized Cancer Treatment Unveiling Genetic Markers and Therapies

Growth Opportunity 2: Personalized Cancer Treatment Unveiling Genetic Markers and Therapies (continued)

Growth Opportunity 3: Leveraging Next-gen Molecular Diagnostics Technologies for Biomarker Development and Companion Diagnostics Integration

Growth Opportunity 3: Leveraging Next-gen Molecular Diagnostics Technologies for Biomarker Development and Companion Diagnostics Integration (continued)

Growth Opportunity 4: Enhancing Home Health Monitoring

Growth Opportunity 4: Enhancing Home Health Monitoring (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

Legal Disclaimer

Request Sample
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts
Related Research
  1. Direct-to-Consumer Wellness Testing Growth Opportunities
    $2,450.00 Release Date: 17-Jan-24
  2. Molecular Diagnostics for Neurodegenerative Diseases: Technology Growth Opportunities, 2024 2028
    $4,950.00 Release Date: 19-Jun-24
  3. Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024 2029
    $4,950.00 Release Date: 26-Aug-24
  4. Smartphone-based Point-of-care Testing Innovations and Growth Opportunities
    $4,950.00 Release Date: 12-Jun-24
  5. Innovation Waves in Immuno-oncology Therapy Development
    $4,950.00 Release Date: 12-Feb-24

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The global molecular diagnostic market will experience significant growth due to a broad range of factors, such as increased demand from the COVID-19 pandemic, an increasing number of cancer cases, and the swift evolution of technological capabilities. Technological advancements, such as polymerase chain reaction (PCR), digital PCR, and next-generation sequencing (NGS), have improved molecular testing accuracy and productivity, enabling personalized treatment. The forecast analysis is segmented by region and by application. The latter includes infectious disease testing, oncology testing, genetic testing, and other molecular diagnostics. Frost & Sullivan s forecasts for this industry use a qualitative approach for the growth opportunity analyses due to methodological constraints. The growing prevalence of cancer has accelerated the need for advanced molecular diagnostic tools, while the rise in chronic diseases, the modernization of government healthcare, and the growing demand for personalized medicine will contribute to the significant growth anticipated in the molecular diagnostics industry. Focused healthcare regulations and substantial R&D investments facilitate this expansion.
More Information
Deliverable Type Market Research
Author Chandni Hussain
Industries Chemicals and Materials
No Index No
Is Prebook No
Podcast No
WIP Number PFEE-01-00-00-00